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Fertility parameters of dairy cows with
cystic ovarian disease after treatment
with gonadotrophin-releasing hormone
G. A. HOOIJER, M. A. A. J. VAN OIJEN, K. FRANKENA, M. M. H. VALKS
Fertility data were collected every four weeks for 10 years from 40 herds of Holstein-Friesian dairy cattle.
The data collected during 925 lactations from cows with cystic ovarian disease which were treated with
500 pg gonadorelin were compared with data from a control group of 13,869 normal lactations. The intervals
between parturition and first insemination and between parturition and conception were significantly
shorter (P<0-001) in the normal cows, but the interval between first insemination and conception was not.
The overall conception rate tended to be higher (P<0-10) in the normal cows, but the conception rate after
the first insemination was significantly higher (P<0-001) and the number of services per conception was
significantly lower (P=0-008) in the normal cows.
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CYSTIC ovarian disease is an important reproductive disor-
der in dairy cows. It is defined as the persistence of an anovu-
latory follicular structure with a diameter of more than 2-5
cm on one or both ovaries in the absence of a corpus luteum
(Kesler and Garverick 1982, Lopez-Diaz and Bosu 1992),
which results in a disturbance of reproductive function.
Boryczko and others (1995) distinguished between follicular
cysts, luteal cysts and intermediate cysts on the basis of the
concentration of progesterone and oestradiol- 17I in the cysts,
and there is a broad variation in the number, size and type
of cysts, resulting in a variety of clinical signs (Kasari and oth-
ers 1996). Clinically, the disturbance of reproductive function
is most frequently (62 to 85 per cent) characterised by
anoestrus (Day 1991, Watson and Cliff 1997) caused by the
production of progesterone by more or less luteinised cysts.
However, nymphomania and irregular cycles are also quite
common (Kasari and others 1996). It is not always easy to
identify the type of cyst in an anoestrous cow (Jeffcoate and
Ayliffe 1995), but this is not clinically important, because
the response to treatment with gonadotrophin-releasing
hormone (GnRH) is the same irrespective of the type of cyst
(Dinsmore and others 1989, Day 1991).
The incidence of the condition varies between 5 and 30 per
cent (Kesler and Garverick 1982, Lopez-Diaz and Bosu 1992,
Laporte and others 1994, Hooijer and others 2001). The time
at which a cow is examined in relation to calving is partly
responsible for this wide variation (Opsomer and others
1996), because a substantial number of the cows which
develop cystic ovaries re-establish ovarian cyclicity sponta-
neously (Kesler and Garverick 1982, Roberts 1986).
There are several treatments for cystic ovarian disease,
including prostaglandin F2oc (PGF2,u), human chorionic
gonadotrophin (hCG), GnRH and progesterone. PGF2 induces
luteal cysts to regress, and signs of oestrus can be observed
within two or three days of treatment (Kesler and Garverick
1982); hCG has luteinising hormone (LH) activity, and induces
luteinisation; GnRH also induces LH release, and oestrus usu-
ally occurs within four weeks of treatment (Dinsmore and
others 1990). Repeated treatments with GnRH at seven-day
intervals give a higher rate of recovery than a single treatment
(Eissa and El-Belely 1995). The administration of proges-
terone, via an ear implant or intravaginal device for nine to
10 days together with oestradiol induces the cyst to regress by
suppressing its LH and follicle-stimulating hormone (FSH)
support via a negative feedback mechanism. After the regres-
sion of the cyst, a new wave of follicles emerges (Roche and
others 1997).
The most important parameter for determining the eco-
nomic losses due to cystic ovarian disease is the interval
between parturition and conception (Scholl and others 1992),
that is, the sum of the intervals from calving to insemination
and from insemination to conception; the interval from
insemination to conception is increased if more than one
service is required.
The aim of this study was to compare the fertility para-
meters of dairy cows with cystic ovarian disease which had
been treated with GnRH from 30 days after calving with those
of normal healthy cows.
MATERIALS AND METHODS
Herd characteristics
Forty Holstein-Friesian dairy herds in the northern
Netherlands were monitored for 10 years according to a stan-
dard protocol; the study started in November 1986. Fertility
data were collected every four weeks during herd health mon-
itoring visits. Eighteen of the farms were visited by the same
practitioner and the other farms were visited by six practi-
tioners who all used the same protocol. In 36 of the herds, the
animals were kept in loose housing with slatted floors, and
in the other four they were kept in tie-stalls. Twenty-seven of
the herds had between 25 and 75 cows and 13 had more than
75 cows.
Data collection
All the gynaecological findings and treatments were recorded
in the veterinary automated management production con-
trol program for dairy farms (vAMPP) (Noordhuizen and
Buurman 1984), and data were recorded from 19,440 lacta-
tions. From these were excluded: lactations during which the
pregnancy diagnosis was unknown; lactations with a calv-
ing-to-conception interval less than 50 days and more than
250 days; lactations with an interval between calving and
first treatment for cystic ovarian disease of less than 30 days
or more than 170 days; lactations during which the treat-
ment included medication other than GnRH; lactations in
which the cow was not inseminated after treatment; and lac-
tations in which the treatment took place on the day of
insemination.
The following protocol was used to collect information
about the fertility parameters. All the animals were investi-
gated by rectal examination between 30 and 60 days after par-
turition. If they were not pregnant after at least three
inseminations (repeat breeder), they were also examined. An
animal was diagnosed with cystic ovarian disease if follicles
with a diameter greater than 2-5 cm were detected on one or
both ovaries in the absence of a corpus luteum; animals in
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which the condition was diagnosed were treated with 500 pg
gonadorelin (Fertagyl; Akzo-Intervet) when they were diag-
nosed. Animals treated for the condition but not yet insemi-
nated were monitored for a recurrence four weeks later and
treated again if necessary. A rectal examination for pregnancy
diagnosis was made between 40 and 70 days after the last
insemination; and treated cows that were inseminated before
the visit four weeks later were re-examined at the pregnancy
diagnosis or as a repeat breeder.
Design and analysis
The data set was divided into two groups: 925 lactations of
cows treated for cystic ovarian disease with GnRH, and 13,869
lactations of cows without the condition. These groups were
compared with respect to the following variables: the inter-
val in days between parturition and conception; the inter-
val in days between parturition and first insemination; the
interval in days between first insemination and conception
for the normal group, and the interval between the first
insemination after treatment and conception for the group
with cystic ovarian disease; the conception rate (%); the
conception rate (%) after first insemination; and the
number of services per conception, that is, the number of
inseminations per pregnancy.
When a herd was entered into the study in 1987, only data
for cows which were pregnant were included in the dataset.
The data from 1987 were therefore removed from the multi-
variate analysis of conception rate and conception rate after
first insemination.
SAS (1989) and STATACORP (1997) software were used for
the statistical evaluation. First, the significance of the differ-
ence between the groups with respect to conception rate,
conception rate after first insemination and number of ser-
vices per conception was analysed by using a chi-squared test.
Because most classes with five or more inseminations con-
tained fewer than five observations, these classes were com-
bined for the chi-squared test. Secondly, to correct for
possible confounding effects such as herd, parity, year of par-
turition and interval between parturition and first insemi-
nation, logistic regression was applied to conception (no/yes)
and conception after first insemination (no/yes), with cys-
tic ovarian disease as the main effect. Poisson regression was
used to correct the number of services per conception for
herd, parity, year of parturition and interval between partu-
rition and first insemination and to estimate the incidence
rate ratio (IRR) for the two groups. Biologically plausible
interactions were tested. The model-building strategies for
logistic and poisson regression were devised according to
Hosmer and Lemeshow (1989). Plots of the Kaplan-Meier
survival function (Kaplan and Meier 1958) were used to
describe the time-related variables (the interval between par-
turition and conception, the interval between parturition
and first insemination, and the interval between first insem-
ination after treatment and conception). The log-rank test
was used to compare the time-related variables of the two
groups.
RESULTS
Descriptive results
After selection, the data set consisted of 14,794 lactations,
including 925 for cows with cystic ovarian disease (6.3 per
cent). However, only 817 cows were diagnosed with the con-
dition because 82 were affected in two lactations, 10 were
affected in three lactations, and two cows were affected in
four lactations. In 854 of the lactations (92-3 per cent) the
cows were treated once, in 66 (7.1 per cent) they were treated
twice, and in five (0.59 per cent) they were treated three
times.
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Statistical analysis
The cumulative percentages of the cows which conceived in
relation to days after calving were significantly different
(P<000 1) for the two groups, with 50 per cent of the healthy
cows having conceived after 96 days compared with 115 days
for the cows with cystic ovarian disease (Fig 1). The cumula-
tive percentages of cows which had been inseminated after
calving were also significantly different between the groups
(P<0001) according to the log-rank test, with 50 per cent of
the normal cows having been served after 77 days, compared
with 89 days for the affected cows (Fig 2). Because both
graphs are based only on the cows that conceived, the cumu-
lative percentages both add up to 100 per cent. The interval
between first insemination (in the affected group after treat-
ment only) and conception did not differ significantly
between the groups (Fig 3).
The results of analyses of the conception rate, the con-
ception rate after first insemination and the number of ser-
vices per conception are summarised in Table 1. The
conception rates were 93 7 per cent for the normal group and
90 9 per cent for the affected group. In the univariate analy-
sis the difference between the groups was significant
(P<000 1), but in the multivariate analysis the difference was
not significant (P=0.053). The conception rate after first
insemination was significantly higher (P<0001) in the nor-
mal group (51-1 per cent) than in the affected group (45.6
per cent). The effects of herd, year of parturition, parity and
interval between calving and first insemination were signif-
icant (P<0.05) in both models for the conception rate and
conception rate after first insemination. There were no sig-
nificant interactions. Cystic ovarian disease tended to be
associated with conception (observed ratio [OR] = 1-27) and
it was significantly associated with conception after first
insemination (oR=- 38). These results agree with the results
of the chi-squared test.
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Number of Univariate Multivariate
Group lactations Mean (%) P value (OR/IRR) 95% Cl
Conception rate COD 925 90.9 <0O001 1.27* 0-97-1-62
Non-COD 13,869 93.7
Conception rate after COD 925 45-6 <0001 1.38t 1-20-1-58
first insemination Non-COD 13,869 51.1
Services per conception COD 841 1.78 015 1-08* 1*02-1-13
Non-COD 12,995 1.72
* P=0.053
t P,0-.O1
t P=0-008
OR Observed ratio, IRR Incidence rate ratio, CI Confidence interval
In the final model for the number of services per concep-
tion, the effect of cystic ovarian disease was corrected for herd
and the interval between parturition and first insemination.
The condition was significantly associated with an increased
number of services per conception (IRR= 1-08) (P=0.008). The
correction for possible confounding effects thus changed the
preliminary conclusions, based on the univariate analysis,
with respect to the number of services per conception.
DISCUSSION
The fertility parameters of cows with cystic ovarian disease
which were given one or more treatments with GnRH were
compared with those of a large control group of cows.
Matching the cows in the control group would not have been
an acceptable alternative because too few cows would have
remained after correcting for farm, season and calving
pattern.
To be able to compare the results of similar studies of cys-
tic ovarian disease, it is essential that the diagnosis of the con-
dition is consistent. In this study, the diagnosis was made by
experienced veterinarians by rectal palpation. They followed
the protocol for fertility monitoring carefully and did not dif-
ferentiate between follicular and luteal cysts, because it is not
possible by rectal palpation alone and is not relevant in terms
of the response to treatment (Dinsmore and others 1989,
Opsomer and others 1998). Ultrasonography was not used
because the technique was not available when the study began.
The time after parturition when the cow is examined is criti-
cal if reliable results are to be obtained (Opsomer and others
1996). According to the standard protocol, the first examina-
tion was made from 30 days after calving, because the condi-
tion is common in cows shortly after calving and has a
spontaneous recovery rate of nearly 60 per cent (Kesler and
Garverick 1982). In exceptional cases, treatment was given less
than 30 days after calving, but these lactations were excluded
from the analysis. Lactations with treatments on the day of
insemination were also excluded because these repeat-breed-
ing cows were treated with GnRH to improve their fertility
rather than to treat cystic ovarian disease. Culled animals were
included in the dataset until they were culled, and, because the
reasons for culling were either not evaluated or multiple in
nature, the reason for culling was not included in the analyses.
The affected animals were treated with GnRH, which causes
the release ofendogenous LH (Youngquist 1986), luteinisation
of the cyst and a recovery of normal cyclical activity
(Hernandez-Ledema and others 1982). In a field study in the
Netherlands, 50 per cent of cows treated for the condition
with GnRH were inseminated within 24 days of treatment.
More than 50 per cent of the cows which became pregnant
after treatment needed only one insemination (Hooijer and
others 1999).
The interval between parturition and conception is the
sum of the interval between parturition and first insemina-
tion and the interval between first insemination and concep-
tion. Management factors, such as feeding and heat detection,
play a key role in reducing the interval between parturition
and first insemination (Brand and Guard 1996), because a
negative energy balance and low insulin concentrations after
calving may limit the responsiveness of the ovary to
gonadotrophin stimulation (Butler and Smith 1989, Opsomer
and others 1999). The interval between parturition and first
insemination was longer in the group with cystic ovarian dis-
ease, but the interval between first insemination and concep-
tion was not. The prolongation of the interval between
parturition and conception was therefore due to the pro-
longed interval between parturition and first insemination.
Although the interval between first insemination and con-
ception was not prolonged, the affected animals required
more services before they conceived. This was probably
because, unlike the insemination-to-conception interval, the
number of services per conception was calculated by includ-
ing all the inseminations before the first treatment. The same
applies to the conception rate after the first insemination. The
difference between the outcomes of the univariate and mul-
tivariate analyses in terms of the significance of the concep-
tion rate between the groups can be explained by the
correction for the interval between parturition and first
insemination in the multivariate analysis. It is difficult to
compare the present results with those of other studies,
because of differences in the numbers of cows included, the
choice of treatment, the dosage, the time of treatment after
parturition and the exclusion criteria. The results of this study
show that the time at which cystic ovarian disease is diag-
nosed and treated after parturition is an essential factor in
reducing the interval between parturition and first insemi-
nation, which in turn limits the economic losses caused by the
condition.
Cystic ovarian disease prolonged both the interval between
parturition and first insemination and the interval between
parturition and conception. Furthermore, the cows with
cystic ovarian disease required significantly more services per
conception than the control cows. The treatment of the
affected cows with GnRH did not increase the interval between
insemination and conception after treatment. It is possible to
limit the economic losses due to cystic ovarian disease by
diagnosing and treating it sooner after parturition.
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Disseminated eosinophilic disease
resembling idiopathic hypereosinophilic
syndrome in a dog
1. AROCH, S. PERL, A. MARKOVICS
True idiopathic hypereosinophilic syndrome has been described in human beings and cats, but not in dogs.
The syndrome is characterised by prolonged unexplained peripheral mature eosinophilia, the infiltration of
many organs by eosinophils, organ dysfunction and a fatal outcome. This paper describes an idiopathic
disseminated eosinophilic disease in a dog involving various organs, manly the heart and the lungs,
accompanied by a leukemoid eosinophilic response, and a fatal outcome. The histopathological findings
included the infiltration of the myocardium, lung parenchyma, liver, spleen, lymph nodes and skeletal
muscles with eosiniphils.
THE idiopathic hypereosinophilic syndrome (HES) has been
described in human beings and cats (Chusid and others
1975, Parrillo and others 1979, Fauci and others 1982,
McEwen and others 1985, Harvey 1990, Neer 1991, Saxon
and others 1991, Gallin 1994). Disseminated eosinophilic
disease has also been described in a ferret and in two dogs.
However, the ferret had a concurrent lymphoma, and both
the dogs were infested by helminth parasites, which could
have been the reason for the eosinophilia (Goto and others
1983, Blomme and others 1999). These cases do not fit the
classic signs of HES which is characterised by a prolonged
eosinophilia (eosinophils >1-5 x 109/litre) with no recognis-
able cause, organ dysfunction and often a fatal outcome.
Many organs may be involved, including the heart, lungs,
spleen, liver, blood, bone marrow, skin, gastrointestinal tract
and nervous system (Neer 1991, Gallin 1994). The histolog-
ical lesions consist mainly of the infiltration of tissues with
eosinophils (Neer 1991, Gallin 1994). In human beings, car-
diovascular lesions are present in approximately 84 per cent
of the patients, predominantly in the left cardiac chamber
(Davies and others 1983). In cats, cardiac lesions have been
reported less frequently, and the main organs involved are the
bone marrow, small intestine, mesenteric lymph nodes and
the liver. A thorough search of the veterinary literature did
not reveal a previous report of true HES in dogs. This paper
describes a dog with idiopathic disseminated eosinophilc dis-
ease resembling HES, accompanied by a severe peripheral
mature eosinophilia.
CASE REPORT
A six-and-a-half-year old intact male German shepherd dog
had been depressed, anorexic, intolerant of exercise and list-
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